Helus Pharma has announced the appointment of Michael Cola as Chief Executive Officer, effective February 10, 2026. With over 30 years of industry experience, Mr. Cola is poised to lead the company into its next growth phase.
Company Information
Company
Helus Pharma
Location
Toronto, Ontario, Canada
About
Helus Pharma is a mental health-focused biopharmaceutical company developing small-molecule Novel Serotonergic Agonists (NSAs) to improve treatment options. The company is advancing patient-centered innovation through clinical excellence to deliver meaningful and durable outcomes that support long-term healing.
Fundz sees it the moment Helus Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.